COVID-19 oral antiviral treatments

COVID-19 oral antiviral treatments, Paxlovid and Lagevrio, began transitioning to the commercial market on November 1, 2023. If you get sick, Paxlovid and Lagevrio will continue to be available during and after this transition. Patient assistance programs are available to people who are underinsured, uninsured, or on Medicaid or Medicare to lower their out-of-pocket costs. Call ahead to your healthcare provider and insurer to confirm supply and coverage eligibility.